Status:
COMPLETED
Reduction of Anterior Glenohumeral Dislocation in Ventral Decubitus Versus Dorsal Decubitus Under Procedural Sedation
Lead Sponsor:
Hopital Nord Franche-Comte
Conditions:
Reduction
Emergencies
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The anterior glenohumeral dislocation is frequently encountered in emergency medicine. It represents about 50% of the total dislocation and affects 1 resident for 10 000 in France. In Nord Franche-Co...
Eligibility Criteria
Inclusion
- Patients with radiological confirmed anterior glenohumeral dislocation
- Patient affiliated or entitled to a social security scheme
- Oral informed consent form
Exclusion
- Glenohumeral fracture or vasculoneural lesion associated
- Dislocation for more than 12 hours
- Homolateral shoulder surgery antecedent
- Contraindication to other analgesics (morphine, sedation)
- BMI \> 40
- Patient \< 18 year
- Pregnancy or nursing woment
- Person under guardianship or curatorship
Key Trial Info
Start Date :
July 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04823689
Start Date
July 21 2021
End Date
June 25 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Nord Franche-Comté
Belfort, France